Literature DB >> 12021387

pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor alpha, an estrogen-responsive element, and the activator protein 1 response element.

Tomas Barkhem1, Lars-Arne Haldosén, Jan-Ake Gustafsson, Stefan Nilsson.   

Abstract

The pS2 promoter is complex with binding sites for a number of protein factors that may participate in modulating its activity. The pS2 gene was transcriptionally activated by estrogens in HepG2 cells transformed (HepER3) to express the estrogen receptor alpha (ERalpha). The phorbol ester phorbol 12-myristate 13-acetate (PMA) stimulated pS2 expression in both HepER3 and the parental, non-ER-expressing HepG2 cells, although its activity was substantially less in HepG2 cells. The use of selective protein kinase inhibitors suggested that the MAPK pathway contributes substantially to estrogen stimulation of the pS2 promoter. The activator protein 1 (AP1) site at -332 to -338 in the pS2 promoter had a dominant role in the response to both estrogens and PMA, although the estrogen response element at -393 to -405 was essential to mediate the response to estrogen. The potentiation of pS2 promoter activity by the AP1 motif in response to estrogen was dependent on the ligand binding domain of ERalpha. Furthermore, the presence of an intact AP1 element in the pS2 promoter sustained suppression of pS2 promoter activity by an LXXLL peptide. In summary, the data suggest that the effect of estrogen is mediated through a cross-talk between the estrogen-responsive element and the AP1 response element and that ERalpha plays a crucial role in mediating the effect of both estrogen and PMA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12021387     DOI: 10.1124/mol.61.6.1273

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  13 in total

Review 1.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.

Authors:  Chunyu Wang; Julie Ann Mayer; Abhijit Mazumdar; Kirsten Fertuck; Heetae Kim; Myles Brown; Powel H Brown
Journal:  Mol Endocrinol       Date:  2011-08-11

Review 3.  Transcription in four dimensions: nuclear receptor-directed initiation of gene expression.

Authors:  Raphaël Métivier; George Reid; Frank Gannon
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

4.  SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).

Authors:  Chunyu Wang; Ivan P Uray; Abhijit Mazumdar; Julie Ann Mayer; Powel H Brown
Journal:  Breast Cancer Res Treat       Date:  2012-01-03       Impact factor: 4.872

5.  Inflammatory regulation of steroid sulfatase: A novel mechanism to control estrogen homeostasis and inflammation in chronic liver disease.

Authors:  Mengxi Jiang; Marcus Klein; Ulrich M Zanger; Mohammad K Mohammad; Matthew C Cave; Nilesh W Gaikwad; Natasha J Dias; Kyle W Selcer; Yan Guo; Jinhan He; Xiuhui Zhang; Qiujin Shen; Wenxin Qin; Jiang Li; Song Li; Wen Xie
Journal:  J Hepatol       Date:  2015-07-26       Impact factor: 25.083

6.  Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination.

Authors:  H Jeong; S Choi; J W Song; H Chen; J H Fischer
Journal:  Xenobiotica       Date:  2008-01       Impact factor: 1.908

7.  DHEA metabolites activate estrogen receptors alpha and beta.

Authors:  Kristy K Michael Miller; Numan Al-Rayyan; Margarita M Ivanova; Kathleen A Mattingly; Sharon L Ripp; Carolyn M Klinge; Russell A Prough
Journal:  Steroids       Date:  2012-11-02       Impact factor: 2.668

Review 8.  Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Authors:  Stephen Safe; Kyounghyun Kim; Kyoungkim Kim
Journal:  J Mol Endocrinol       Date:  2008-09-04       Impact factor: 5.098

9.  Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy.

Authors:  Huiqing Chen; Kyunghee Yang; Suyoung Choi; James H Fischer; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2009-06-22       Impact factor: 3.922

10.  Identification of four novel phosphorylation sites in estrogen receptor alpha: impact on receptor-dependent gene expression and phosphorylation by protein kinase CK2.

Authors:  Christopher C Williams; Aninda Basu; Abeer El-Gharbawy; Latonya M Carrier; Carolyn L Smith; Brian G Rowan
Journal:  BMC Biochem       Date:  2009-12-31       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.